NUVISAN The Science CRO
Maike Marczenke is an Associate Scientist at Nuvisan since September 2022, specializing in therapeutic and cross indication research with a focus on iPSC-based cellular systems for drug development. Previous experience includes marketing and event support at LabTwin, where Maike organized international conferences and created scientific marketing content. As a PhD student at the Max Delbrück Center, Maike conducted research on SHH co-receptors in brain development using mouse models and iPSCs. Maike also completed an internship in drug target discovery at Bayer Pharmaceuticals and established a disease model for atrial fibrillation during a master's thesis at the Max-Planck Institute. Educational qualifications include a PhD from Freie Universität Berlin and master's and bachelor's degrees in molecular biomedicine and molecular biology, respectively.
NUVISAN The Science CRO
1 followers
Founded in Europe with more than 40 years of experience, NUVISAN is a fully integrated contract research and development, and manufacturing organization (CRO/CDMO) that offers unique, high-quality, and tailored integrated solutions along the drug discovery and development value chain. With more than 1.000 employees distributed over six locations in Germany and France including our drug discovery hub in Berlin as well as with local experts situated in Latin America, NUVISAN is pleased to offer the following portfolio of services: • Drug discovery & research - Discovery pharmacology - Discovery bioscience - Screening - Life science chemistry - Translation research - Digital life science - Toxicology - DMPK • Non-clinical studies • Pharmaceutical analysis • Topical formulation development • Chemical development with GMP manufacturing (3-10kg) • Bioanalytical labs • GMP manufacturing (up to 50Kg) • Clinical trial supplies • Phase 1 and 2 clinical studies and beyond Our services can be provided as stand-alone or integrated solutions and can be customized to your project. Email us at hello@nuvisan.com for more.